2.7.11.20	Acidosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12416990&form=6&db=m	Regulation of elongation factor-2 kinase by pH.	causal interaction,therapeutic application,unassigned	4,3,0	
2.7.11.20	Acidosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25670349&form=6&db=m	Regulated stability of eukaryotic elongation factor 2 kinase requires intrinsic but not ongoing activity.	ongoing research,therapeutic application,unassigned	3,4,0	
2.7.11.20	Acidosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25776553&form=6&db=m	Molecular Mechanism for the Control of Eukaryotic Elongation Factor 2 Kinase by pH: Role in Cancer Cell Survival.	causal interaction,diagnostic usage,ongoing research,therapeutic application	3,4,4,2	
2.7.11.20	Acidosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33673713&form=6&db=m	Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy.	causal interaction,therapeutic application,unassigned	4,4,0	
2.7.11.20	Acquired Immunodeficiency Syndrome	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29186827&form=6&db=m	Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer.	causal interaction,diagnostic usage,therapeutic application,unassigned	4,3,4,0	
2.7.11.20	Adenocarcinoma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34352439&form=6&db=m	eEF2K as a novel metastatic and prognostic biomarker in gastric cancer patients.	causal interaction,diagnostic usage,ongoing research,therapeutic application	2,4,4,3	
2.7.11.20	Adenocarcinoma of Lung	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30890561&form=6&db=m	Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress.	causal interaction,ongoing research,therapeutic application,unassigned	1,4,1,0	
2.7.11.20	Alzheimer Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16098202&form=6&db=m	Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain.	causal interaction,unassigned	3,0	
2.7.11.20	Alzheimer Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30667373&form=6&db=m	Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice.	causal interaction,ongoing research,therapeutic application,unassigned	4,2,1,0	
2.7.11.20	Anemia	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17110456&form=6&db=m	Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias.	causal interaction,unassigned	1,0